Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Ray, Kausik K
765  Ergebnisse:
Personensuche X
?
1

Evolocumab use in clinical practice in Switzerland: final d..:

Sudano, Isabella ; Krähenbühl, Stephan ; Mach, François...
Therapeutic Advances in Cardiovascular Disease.  18 (2024)  - p. , 2024
Link: https://doi.org/10.1177/..
 
?
2

Inclisiran in individuals with diabetes or obesity: Post ho..:

Leiter, Lawrence A. ; Raal, Frederick J. ; Schwartz, Gregory G....
Diabetes, Obesity and Metabolism.  , 2024
Link: https://doi.org/10.1111/..
 
?
3

Evaluating the effect of bempedoic acid on kidney function:..:

Ray, Kausik K ; Bloedon, LeAnne ; Li, Na.
The Lancet Diabetes & Endocrinology.  12 (2024)  4 - p. 228-229 , 2024
Link: https://doi.org/10.1016/..
 
?
4

Efficacy and safety of bempedoic acid among patients with a..:

Ray, Kausik K ; Nicholls, Stephen J ; Li, Na...
The Lancet Diabetes & Endocrinology.  12 (2024)  1 - p. 19-28 , 2024
Link: https://doi.org/10.1016/..
 
?
5

Inclisiran administration potently and durably lowers LDL-C..:

Wright, R Scott ; Raal, Frederick J ; Koenig, Wolfgang...
Cardiovascular Research.  , 2024
Link: https://doi.org/10.1093/..
 
?
6

Overview of a collaborative global effort to address the bu..:

Lyons, Alexander R.M. ; Stevens, Christophe A.T. ; Dharmayat, Kanika I...
Indian Heart Journal.  76 (2024)  - p. S113-S116 , 2024
Link: https://doi.org/10.1016/..
 
?
7

Evolocumab-Based LDL-C Management in High and Very High Car..:

Lehrke, Michael ; Vogt, Anja ; Schettler, Volker...
Advances in Therapy.  41 (2024)  3 - p. 1184-1200 , 2024
Link: https://doi.org/10.1007/..
 
?
8

Cardiovascular outcomes in patients with homozygous familia..:

Reijman, M Doortje ; Tromp, Tycho R ; Hutten, Barbara A...
The Lancet Child & Adolescent Health.  , 2024
Link: https://doi.org/10.1016/..
 
?
9

Impact of the 2021 European Society for Cardiology preventi..:

Holtrop, Joris ; Bhatt, Deepak L ; Ray, Kausik K...
European Journal of Preventive Cardiology.  31 (2024)  6 - p. 754-762 , 2024
Link: https://doi.org/10.1093/..
 
?
10

Estimating potential cardiovascular health benefits of impr..:

Ray, Kausik K. ; Gunn, Laura H. ; Conde, Lorena Garcia...
Atherosclerosis.  391 (2024)  - p. 117472 , 2024
Link: https://doi.org/10.1016/..
 
?
11

Atherosclerosis evaluation and cardiovascular risk estimati..:

Nurmohamed, Nick S ; van Rosendael, Alexander R ; Danad, Ibrahim...
European Heart Journal.  45 (2024)  20 - p. 1783-1800 , 2024
Link: https://doi.org/10.1093/..
 
?
12

Efficacy and safety of bempedoic acid in patients with hete..:

Duell, P. Barton ; Banach, Maciej ; Catapano, Alberico L....
Journal of Clinical Lipidology.  18 (2024)  2 - p. e153-e165 , 2024
Link: https://doi.org/10.1016/..
 
?
13

Obicetrapib on top of maximally tolerated lipid‐modifying t..:

Nicholls, Stephen J. ; Nelson, Adam J. ; Ditmarsch, Marc...
American Heart Journal.  274 (2024)  - p. 32-45 , 2024
Link: https://doi.org/10.1016/..
 
?
14

2023 Update on European Atherosclerosis Society Consensus S..:

Cuchel, Marina ; Raal, Frederick J ; Hegele, Robert A...
European Heart Journal.  44 (2023)  25 - p. 2277-2291 , 2023
Link: https://doi.org/10.1093/..
 
?
15

Long-term persistence with evolocumab treatment and sustain..:

Ray, Kausik K. ; Bruckert, Eric ; Peronne-Filardi, Pasquale...
Atherosclerosis.  366 (2023)  - p. 14-21 , 2023
Link: https://doi.org/10.1016/..
 
1-15